RecruitingPhase 3NCT04374799
Heparin vs Placebo for Cardiac Catheterization
A Randomized Trial of Heparin vs Placebo in Patients Undergoing Cardiac Catheterization Via the Trans-radial Approach
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Enrollment
1,623 participants
Start Date
Oct 5, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- diagnostic cardiac catheterization; Small size sheath; patency of the ulno-palmar circulation
Exclusion Criteria1
- abnormal ulno-palmar circulation; Prior radial artery thrombosis; Prior surgery close to the access site; Emergent cardiac catheterization; History of HIT or allergy to heparin; Patients requiring anticoagulation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGHeparin
two doses of heparin
DRUGPlacebos
placebo
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04374799
Related Trials
BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)
NCT0482366326 locations
Left Bundle Branch Area Pacing (LBBAP) PMCF Study
NCT0721739213 locations
Digital diagnoSis of Cardiac sOUNd in peDiatric Patients [DI-SOUND Study]
NCT075425095 locations
Efferon LPS Hemoadsorption in Cardiac Surgery Patients
NCT075321743 locations
Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay
NCT062941191 location